Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8679631 | Thrombosis Research | 2018 | 7 Pages |
Abstract
Moderate FXI deficiency, particularly CRMÂ +, might be underestimated using current diagnostic methods. The activator, FXI and FXII levels may contribute to a higher rate of false negatives using APTT. Our results suggests that the best screening method for FXI deficiency is FXI:C using silica.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Salam Salloum-Asfar, MarÃa E. de la Morena-Barrio, Julio Esteban, Antonia Miñano, Cristina Aroca, Vicente Vicente, Vanessa Roldán, Javier Corral,